Nuveen Asset Management LLC lessened its holdings in shares of Sotera Health (NASDAQ:SHC - Free Report) by 7.1% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 406,655 shares of the company's stock after selling 30,861 shares during the period. Nuveen Asset Management LLC owned 0.14% of Sotera Health worth $5,563,000 at the end of the most recent reporting period.
A number of other institutional investors have also modified their holdings of the business. Irenic Capital Management LP boosted its stake in Sotera Health by 4.3% during the 4th quarter. Irenic Capital Management LP now owns 2,909,163 shares of the company's stock valued at $39,797,000 after purchasing an additional 120,832 shares during the period. D. E. Shaw & Co. Inc. boosted its stake in Sotera Health by 140.8% during the 4th quarter. D. E. Shaw & Co. Inc. now owns 2,624,750 shares of the company's stock valued at $35,907,000 after purchasing an additional 1,534,666 shares during the period. Corton Capital Inc. acquired a new position in Sotera Health during the 4th quarter valued at about $139,000. Brevan Howard Capital Management LP boosted its stake in Sotera Health by 127.0% during the 4th quarter. Brevan Howard Capital Management LP now owns 79,156 shares of the company's stock valued at $1,083,000 after purchasing an additional 44,280 shares during the period. Finally, Bridgefront Capital LLC acquired a new position in Sotera Health during the 4th quarter valued at about $185,000. Institutional investors own 91.03% of the company's stock.
Sotera Health Price Performance
SHC stock traded up $0.08 on Wednesday, hitting $12.36. 1,202,293 shares of the company's stock traded hands, compared to its average volume of 1,200,266. Sotera Health has a 1-year low of $9.53 and a 1-year high of $17.08. The stock has a market cap of $3.51 billion, a price-to-earnings ratio of 49.44 and a beta of 1.87. The stock has a fifty day moving average of $11.71 and a 200-day moving average of $12.57. The company has a current ratio of 2.88, a quick ratio of 2.61 and a debt-to-equity ratio of 4.91.
Sotera Health (NASDAQ:SHC - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The company reported $0.14 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.12 by $0.02. Sotera Health had a net margin of 6.31% and a return on equity of 42.27%. The business had revenue of $254.52 million for the quarter, compared to analyst estimates of $245.56 million. During the same quarter in the previous year, the business earned $0.13 earnings per share. The firm's revenue was up 2.6% compared to the same quarter last year. On average, analysts forecast that Sotera Health will post 0.61 EPS for the current fiscal year.
Wall Street Analyst Weigh In
A number of research analysts have issued reports on the stock. Barclays reduced their target price on shares of Sotera Health from $16.00 to $12.00 and set an "overweight" rating for the company in a research note on Thursday, April 10th. Piper Sandler reduced their target price on shares of Sotera Health from $15.00 to $13.00 and set a "neutral" rating for the company in a research note on Wednesday, April 23rd. Finally, The Goldman Sachs Group raised shares of Sotera Health from a "neutral" rating to a "buy" rating and boosted their target price for the company from $14.00 to $17.00 in a research note on Monday, May 5th. One analyst has rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $15.80.
Read Our Latest Report on Sotera Health
About Sotera Health
(
Free Report)
Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.
Read More

Before you consider Sotera Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sotera Health wasn't on the list.
While Sotera Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.